Lobbying Filing Details

Activity 1

Copyright/Patent/Trademark

Federal Trade Commission related issues, no specific bill Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS waiver, no specific bill Issues related to patent thickets/product hopping Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes

Lobbyists (2)

• WILLIAM O'BRIEN
• HELEN RHEE

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 2

Health Issues

Issues related to drug pricing Changes to Public law 117-1769 Inflation Reduction Act Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues pertaining to the implementation of PL 97-414 "Orphan Drug Act," all provisions. Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to pediatric priority review voucher reauthorization HR 946 Optimizing Research Progress Hope and New Cures Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 2214 DRUG Act H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act

Lobbyists (12)

• GREGORY PORTNER
• JESSE KERNS
• HOWARD MOON
• L NICOLE CURRIE
• WILLIAM O'BRIEN
• HELEN RHEE
• RUTH HOFFMAN
• MRS. JORDAN LYNN LAYSON
• MS. KIMBERLY LOVE
• MR. MATTHEW MCMURRAY
• CHAD PETTIT
• CHASE THOMAS

Government Entities (3)

• SENATE
• HOUSE OF REPRESENTATIVES
• Health & Human Services, Dept of (HHS)

Activity 3

Medicare/Medicaid

Issues related to drug pricing Changes to Public law 117-1769 Inflation Reduction Act Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act Issues related to cardiovascular disease awareness and treatment Issues related to reimbursement for biologics/biosimilars Issues related to PBM reform Issues related to bone disease awareness and treatment HR 946 Optimizing Research Progress Hope and New Cures Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14)

Lobbyists (12)

• GREGORY PORTNER
• JESSE KERNS
• HOWARD MOON
• L NICOLE CURRIE
• WILLIAM O'BRIEN
• HELEN RHEE
• RUTH HOFFMAN
• MRS. JORDAN LYNN LAYSON
• MS. KIMBERLY LOVE
• MR. MATTHEW MCMURRAY
• CHAD PETTIT
• CHASE THOMAS

Government Entities (4)

• SENATE
• HOUSE OF REPRESENTATIVES
• Health & Human Services, Dept of (HHS)
• Centers For Medicare and Medicaid Services (CMS)

Activity 4

Tariff (miscellaneous tariff bills)

Issues related to tariffs.

Lobbyists (10)

• GREGORY PORTNER
• JESSE KERNS
• HOWARD MOON
• L NICOLE CURRIE
• WILLIAM O'BRIEN
• HELEN RHEE
• MRS. JORDAN LYNN LAYSON
• MS. KIMBERLY LOVE
• MR. MATTHEW MCMURRAY
• CHASE THOMAS

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES